Research record

EXPRESS: Rapamycin increases cerebral blood flow and modulates metabolic, inflammatory, and microbiome profiles in healthy middle-aged APOE4 carriers: a pilot single-arm trial.

Research record, indexed because it matched monitored longevity research terms. Inclusion in this index does not establish that an intervention is effective or safe.

Published
September 10, 2026
Authors
Aware C, Neher CM, Woods C, Khegai O, Dwivedi AK, Govindarajan M, Ivanich K, Kurt M, Beversdorf D, Cheng J, Bresette N, Cui T, Balchandani P, Gonzales MM, Ericsson AC, Altes T, Lin AL.
DOI
10.1177/0271678x261490342
Evidence class
research-record
Record status
published
Match confidence
75%
Citations
0
Source feed
Europe PMC
Automated source synopsis

Research record, indexed because it matched monitored longevity research terms. Inclusion in this index does not establish that an intervention is effective or safe.

Why this record matched · 75% confidence

Published automatically with 75% topic confidence after controlled-term evaluation.

  • Rapamycin · 75%Legacy record evaluated automatically against controlled title and longevity-context rules.

Source quality 90% · freshness 100%. These are automated routing signals, not medical or evidence-strength ratings.

BibTeX · RIS

rapamycin
Open primary sourceExport JSON